- Report
- January 2023
- 197 Pages
Global
From €4753EUR$5,178USD£3,950GBP
- Report
- November 2020
- 76 Pages
Global
From €4703EUR$4,950USD£4,045GBP
- Report
- April 2023
- 90 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- April 2020
- 105 Pages
Europe
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- April 2020
- 100 Pages
Asia Pacific
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- March 2020
- 134 Pages
North America
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- April 2023
- 175 Pages
Global
€4555EUR$4,795USD£3,919GBP
- Report
- January 2021
- 68 Pages
Middle East, Africa
From €1425EUR$1,500USD£1,226GBP
- Report
- January 2021
- 64 Pages
North America
From €1425EUR$1,500USD£1,226GBP
- Report
- January 2021
- 68 Pages
Asia Pacific
From €1425EUR$1,500USD£1,226GBP
- Report
- April 2019
- 125 Pages
Global
From €5653EUR$5,950USD£4,863GBP
The Biological Threat market is a subset of the Biodefense industry, which focuses on the development of products and services to protect against biological threats. These threats can include naturally occurring diseases, such as pandemics, as well as intentional biological attacks. The market includes a range of products and services, such as vaccines, diagnostics, therapeutics, and decontamination systems. It also includes research and development of new technologies, such as biosecurity systems and bioterrorism detection systems.
The Biological Threat market is driven by the need to protect against the increasing threat of biological attacks and pandemics. Governments, militaries, and healthcare organizations are investing in the development of new technologies and products to protect against these threats.
Some companies in the Biological Threat market include Emergent BioSolutions, DynPort Vaccine Company, and BioThrax. Other companies include BioFire Defense, Cepheid, and BioVeris. Show Less Read more